📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. (2022)

First Author: Marrone L

Attributed to: JPND - Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/14712598.2022.2012148

PubMed Identifier: 34904932

Publication URI: http://europepmc.org/abstract/MED/34904932

Type: Journal Article/Review

Volume: 22

Parent Publication: Expert opinion on biological therapy

Issue: 9

ISSN: 1471-2598